Patient portal study finds disparities in vulnerable populations

The more digital health tools are adopted, the greater the disparities among at-risk populations, according to a study published in the Clinical Journal of the American Society of Nephrology.

Researchers examined about 2,800 patients at four university-affiliated nephrology offices in western Pennsylvania to assess their use of an EHR portal to manage their chronic kidney disease. The review included some 2,800 patients treated between Jan. 1, 2010, and Dec. 31, 2012, who all had at least one additional nephrology follow-up visit conducted before June 30, 2013.

Researchers used EHRs to obtain patients' clinical measurements, comorbidities, office visits and sociodemographic characteristics. About 40 percent of the study participants accessed the portal, with which they could communicate with providers, refill prescriptions, review laboratory results, review medications and schedule or change appointments. 

Study participants learned about the portal through fliers and pamphlets provided at the clinics, but they did not receive any training on how to sign up or use the portal. The top actions were reviewing laboratory results (87 percent), reviewing their medical information (85 percent) and reviewing or altering appointments (85 percent).

Those who used the portal were more likely to be enrolled in private insurance, married, white and younger. Meanwhile, those who did not access the portal were more likely to be black, enrolled in Medicaid or Medicare, lower-income, older and unmarried.

"Despite the increasing availability of smartphones and other technologies to access the internet, the adoption of e-health technologies does not appear to be equitable," said one of the authors, Khaled Abdel-Kader, MD, MS, of the Vanderbilt Center for Kidney Disease. "As we feel we are advancing, we may actually perversely be reinforcing disparities that we had been making progress on."

Further research is needed to understand why vulnerable populations don't access patient portals, the authors concluded. "Future research should examine barriers to the use of e-health technologies in underserved patients with [chronic kidney disease], interventions to address them and their potential to improve outcomes."

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.